FindTrial
Sign In

The Clinic Application of Dexmedetomidine Combined with Caudal Ropivacaine in Children Undergoing Concealed Penis Lengthening

The Application of Dexmedetomidine in Pediatric Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018336
Enrollment
Unknown
Registered
2018-09-12
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric concealed penis

Interventions

Group 2:caudal dexmedetomidine combined with ropivacaine
Group 1:NS

Sponsors

Panzhihua Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: ASA I grade, 80 children aged 1-6 who underwent concealed penile lengthening surgery at the central hospital of panzhihua from October 1, 2018 to April 1, 2019, were selected to be included in the study.

Exclusion criteria

Exclusion criteria: 1) stunted growth and mental retardation; 2) mental disorders; 3) neuromuscular diseases; 4) abnormal coagulation function; 5) history of drug allergy; 6) infection of the puncture site.

Design outcomes

Primary

MeasureTime frame
onset time;—

Countries

China

Contacts

Public ContactYu Zhao

Panzhihua Central Hospital

842572913@qq.com+86 13508230836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026